Sana Biotechnology Inc’s filing revealed that its Officer CHRISTIAN HORDO & KATHARINE HO acquired Company’s shares for reported $0.24 million on Feb 18 ’25. In the deal valued at $3.16 per share,75,000 shares were bought.
Then, CHRISTIAN HORDO & KATHARINE HO bought 75,000 shares, generating $289,500 in total proceeds.
Before that, FMR LLC sold 290,912 shares. Sana Biotechnology Inc shares valued at $1,887,320 were divested by the insider at a price of $6.49 per share. As a result of the transaction, FMR LLC now holds 4,541,511 shares, worth roughly $12.76 million.
Citizens JMP upgraded its Sana Biotechnology Inc [SANA] rating to a Mkt outperform from a a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. TD Cowen also remained covering SANA and has increased its forecast on January 08, 2025 with a “Buy” recommendation from previously “Hold” rating. JMP Securities revised its rating on November 05, 2024. It rated SANA as “a Mkt perform” which previously was an “a Mkt outperform”.
Price Performance Review of SANA
On Tuesday, Sana Biotechnology Inc [NASDAQ:SANA] saw its stock jump 11.51% to $2.81. Over the last five days, the stock has lost -3.44%. Sana Biotechnology Inc shares have risen nearly 72.39% since the year began. Nevertheless, the stocks have fallen -60.70% over the past one year. While a 52-week high of $7.40 was reached on 01/08/25, a 52-week low of $1.26 was recorded on 04/04/25.
Levels Of Support And Resistance For SANA Stock
The 24-hour chart illustrates a support level at 2.61, which if violated will result in even more drops to 2.41. On the upside, there is a resistance level at 2.93. A further resistance level may holdings at 3.05.
The most recent change occurred on June 26, 2024 when Rodman & Renshaw began covering the stock and recommended ‘”a Buy”‘ rating along with a $16 price target.
